Published • loading... • Updated
Bristol Myers Squibb's RayzeBio to build $173 million facility
Summary by Pharmaceutical Processing World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bristol Myers Squibb's RayzeBio to build $173 million facility
RayzeBio, a subsidiary of Bristol Myers Squibb, announced plans to construct a new $173 million facility in Whitestown, Indiana. The 225,000-square-foot facility will be located at the Anson Industrial Park in Boone County and will manufacture radiopharmaceutical therapies (RPTs). Construction is expected to begin this year. The company currently has a 77,000-square-foot RPT supply and manufacturing facility… The post Bristol Myers Squibb’s Razy…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
